Skip to main content
logo
Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ: RXRX · Real-Time Price · USD
3.520
+0.020 (0.57%)
At close: Nov 6, 2026, 4:00 PM EST
3.510
-0.010 (-0.28%)
Pre-market: Nov 9, 2026, 6:03 AM EST

Recursion Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Quarter
CurrentQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Nov '26 Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Market Capitalization
2,1942,2151,9481,6222,1292,1332,0592,1282,6661,8522,0122,3442,1361,6491,4371,2761,4611,8421,4001,2232,895
Market Cap Growth (YoY)
-15.13%3.84%-5.40%-23.80%-20.16%15.19%2.36%-9.21%24.83%12.27%39.99%83.78%46.15%-10.44%2.63%4.32%-49.52%-52.50%-77.21%--
Enterprise Value
1,7191,7361,3669561,5511,6961,6511,6422,3291,4671,7662,0031,8001,2961,0177771,0591,3808617072,317
Last Close Price
3.524.133.673.074.094.885.065.296.766.597.509.979.867.657.476.677.7110.648.147.1617.13

Price Ratios

Fiscal Quarter
CurrentQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Nov '26 Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
PS Ratio
32.1632.4635.5124.4228.5048.8231.8835.5945.3228.4140.5350.7047.9234.8228.7527.3536.6864.1777.4794.43284.42
PB Ratio
2.182.442.131.581.882.042.242.282.583.533.445.844.613.773.062.973.014.753.202.485.33
P/TBV Ratio
4.654.704.132.843.233.794.984.844.854.224.077.425.704.773.932.983.024.773.222.495.35
P/FCF Ratio
--------------------16.26-
P/OCF Ratio
--------------------24.23-

EV Ratios

Fiscal Quarter
CurrentQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Nov '26 Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
EV/Sales Ratio
25.1925.4424.9014.4020.7738.8225.5727.4739.5922.5135.5843.3340.3827.3720.3416.6526.5848.0847.6554.59227.62
EV/FCF Ratio
--------------------9.40-

Financial Efficiency

Fiscal Quarter
CurrentQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Nov '26 Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Debt / Equity Ratio
0.080.080.070.070.070.080.100.100.110.170.150.130.110.120.110.120.110.130.120.110.00
Debt / FCF Ratio
--------------------0.69-
Net Debt / Equity Ratio
-0.52-0.52-0.52-0.57-0.59-0.55-0.47-0.44-0.47-0.64-0.66-0.61-0.74-0.77-0.75-0.98-1.03-1.04-1.05-1.09-0.95
Net Debt / EBITDA Ratio
1.111.111.011.141.170.900.750.781.100.931.050.701.051.141.351.692.111.682.072.722.96
Net Debt / FCF Ratio
1.521.521.361.791.761.291.111.021.301.011.120.741.141.221.331.544.143.024.077.172.60
Asset Turnover
0.050.050.040.050.050.040.060.060.060.100.070.080.070.080.080.070.060.050.030.030.02
Quick Ratio
4.754.754.675.155.204.393.333.853.433.955.544.044.244.153.595.165.515.625.457.0311.27
Current Ratio
5.015.015.035.475.504.603.584.113.814.366.074.654.704.363.785.345.685.805.657.2311.46
Return on Equity (ROE)
-48.72%-48.72%-56.58%-57.16%-59.54%-91.06%-86.34%-86.10%-61.90%-78.49%-71.18%-85.19%-69.12%-70.84%-57.36%-53.87%-46.56%-50.03%-43.30%-59.74%-47.51%
Return on Assets (ROA)
-23.89%-23.89%-27.33%-27.94%-27.72%-42.19%-38.72%-38.11%-28.48%-36.41%-34.36%-39.84%-32.29%-31.57%-25.83%-23.72%-23.42%-24.30%-21.04%-25.87%-25.14%
Return on Capital Employed (ROCE)
-45.60%-45.80%-50.60%-49.10%-49.10%-57.70%-56.60%-48.80%-38.00%-64.00%-57.50%-78.10%-62.50%-58.50%-50.10%-48.80%-41.40%-47.20%-40.60%-32.10%-32.40%

Yields

Fiscal Quarter
CurrentQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Nov '26 Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Earnings Yield
-25.42%-21.48%-26.64%-34.52%-30.29%-33.55%-31.53%-27.01%-17.39%-20.40%-18.64%-15.11%-15.36%-17.74%-18.09%-19.51%-16.39%-13.41%-16.71%-17.32%-6.44%
FCF Yield
-14.24%-14.11%-18.09%-20.09%-17.77%-20.99%-19.13%-18.69%-13.98%-17.95%-17.01%-14.09%-14.03%-16.75%-18.47%-21.33%-8.25%-7.25%-8.10%-6.15%-6.85%
Buyback Yield / Dilution
-32.56%-21.48%-27.58%-31.41%-56.75%-58.18%-72.32%-70.65%-50.58%-31.85%-20.25%-23.17%-20.19%-23.58%-16.96%-12.26%-9.62%-2.91%-24.47%-640.98%-669.39%
SEC Filings: 10-K · 10-Q